Heinz Sill

35PUBLICATIONS
144CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Medical mycologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Nov 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Ulrike Höckendorf, Sayantanee Dutta, Arnold Kloos

|Nov 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.

Sonja Wurm, Michael Waltersdorfer, Simone Loindl

|Mar 28, 2024
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions.

Jennifer Moritz, Antonia Schwab, Andreas Reinisch

|Aug 07, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.

Lisa Pleyer, Marc Vaisband, Manuel Drost

|Feb 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities.

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia

Pageof 6

Frequent Collaborators

18 joint publications

Armin Zebisch

11 joint publications

Albert Wölfler

7 joint publications

Andreas Reinisch

5 joint publications

Gerald Hoefler